The prevalence of neurologic manifestations of syphilis reported among patients with early- and late-stage disease increased between 2019 and 2022.

The CPS-Ped may be an efficient outcome metric for monitoring disease severity and clinical improvement over time among infants with RSV-related critical illness.

No association was observed between serious infection risk and Janus kinase inhibitor use in patients with immune-mediated inflammatory skin disease.

Treatments for COPD, psoriasis, and neuroendocrine tumors, as well as a next-generation COVID-19 vaccine are under review.

The WHO forged a draft agreement seeking to strengthen global collaboration on future pandemic prevention, preparedness, and response.

Governors in Arkansas and Indiana are asking the federal government for permission to ban soda and candy purchases with food stamps.

The US CDC now recommends extra measles protection for people traveling to areas with active outbreaks in the United States.

More than 1700 pounds of butter are being recalled due to possible contamination with coliform, a type of bacteria found in fecal matter.

The US FDA announced it is shifting away from animal testing in the development of monoclonal antibody therapies and other drugs.

The FDA has granted Fast Track designation to Sanofi’s mRNA vaccine candidate for the prevention of chlamydia infection.

The prevalence of hepatitis C virus (HCV) has decreased over time among patients with HIV infection in the United States with the use of direct-acting antiviral (DAA) therapy, according to findings ...

Hospitalization risk for severe mpox disease was significantly higher in patients with vs without HIV coinfection.